- Home
- PTGX vs M Comparison
PTGX vs M Comparison
Compare PTGX & M Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | PTGX | M |
|---|---|---|
| Founded | 2006 | 1830 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Department/Specialty Retail Stores |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 5.4B | 5.2B |
| IPO Year | 2016 | N/A |
Fundamental Metrics
Financial Performance| Metric | PTGX | M |
|---|---|---|
| Price | $89.53 | $22.88 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 9 | 11 |
| Target Price | ★ $86.44 | $19.80 |
| AVG Volume (30 Days) | 898.7K | ★ 7.4M |
| Earning Date | 11-06-2025 | 12-03-2025 |
| Dividend Yield | N/A | ★ 3.19% |
| EPS Growth | N/A | ★ 178.61 |
| EPS | 0.72 | ★ 1.71 |
| Revenue | $209,217,000.00 | ★ $22,712,000,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $296.47 | N/A |
| P/E Ratio | $124.48 | ★ $13.34 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $33.70 | $9.76 |
| 52 Week High | $93.25 | $23.27 |
Technical Indicators
Market Signals| Indicator | PTGX | M |
|---|---|---|
| Relative Strength Index (RSI) | 64.67 | 70.17 |
| Support Level | $83.52 | $21.39 |
| Resistance Level | $90.85 | $23.27 |
| Average True Range (ATR) | 2.63 | 0.97 |
| MACD | -0.33 | 0.16 |
| Stochastic Oscillator | 83.62 | 90.75 |
Price Performance
Historical ComparisonAbout PTGX Protagonist Therapeutics Inc.
Protagonist Therapeutics Inc is a clinical-stage biopharmaceutical company having a proprietary technology platform that enables the discovery and development of novel constrained peptide-based drug candidates to address medical needs. Its pipeline products include Rusfertide (PTG-300) and JNJ-2113.
About M Macy's Inc
Founded in 1858 and based in New York City, Macy's operates about 450 stores under the Macy's name, nearly 60 stores under the Bloomingdale's (full-price and outlet) and Bloomie's names, and more than 170 freestanding Bluemercury specialty beauty stores. Macy's also operates e-commerce sites and licenses Bloomingdale's stores in the United Arab Emirates and Kuwait. Women's apparel, accessories, shoes, cosmetics, and fragrances constitute about 62% of Macy's sales.